Table 2.
Comparison of acetylcholinesterase inhibitor and memantine use during the 4-year follow-up among those diagnosed with Alzheimer’s disease in 2005 in the MEDALZ-2005 study (n=6858)

Comparison of acetylcholinesterase inhibitor and memantine use during the 4-year follow-up among those diagnosed with Alzheimer’s disease in 2005 in the MEDALZ-2005 study (n=6858)
